Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew S Lebo

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
American Journal of Human Genetics|June 6, 2023
Actionability of unanticipated monogenic disease risks in newborn genomic screening: Findings from the BabySeq ProjectRobert C Green, Nidhi Shah, Casie A Genetti, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 23, 2015
Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivityAhmed A Alfares, Melissa A Kelly, Gregory McDermott, et al.
Medrxiv : the Preprint Server for Health Sciences|November 14, 2023
Decoding Genetics, Ancestry, and Geospatial Context for Precision HealthSatoshi Koyama, Ying Wang, Kaavya Paruchuri, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 4, 2015
CORRIGENDUM: Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivityAhmed A Alfares, Melissa A Kelly, Gregory McDermott, et al.
American Journal of Human Genetics|November 9, 2021
Returning actionable genomic results in a research biobank: Analytic validity, clinical implementation, and resource utilizationCarrie L Blout Zawatsky, Nidhi Shah, Kalotina Machini, et al.
Cold Spring Harbor Molecular Case Studies|May 6, 2018
Reconciling newborn screening and a novel splice variant in <i>BTD</i> associated with partial biotinidase deficiency: a BabySeq Project case reportJaclyn B Murry, Kalotina Machini, Ozge Ceyhan-Birsoy, et al.
Journal of the American College of Cardiology|April 29, 2026
Development and Validation of a Clinical Polygenic Risk Report in U.S.-Based Health Systems for 8 Cardiovascular ConditionsAnika Misra, Amanda Jowell, Sara Haidermota, et al.
Genome Medicine|October 7, 2022
Patient and provider perspectives on polygenic risk scores: implications for clinical reporting and utilizationAnna C F Lewis, Emma F Perez, Anya E R Prince, et al.
Human Mutation|June 10, 2020
An assessment of the role of vinculin loss of function variants in inherited cardiomyopathyMegan H Hawley, Naif Almontashiri, Leslie G Biesecker, et al.
Nature Medicine|April 19, 2022
Development of a clinical polygenic risk score assay and reporting workflowLimin Hao, Peter Kraft, Gabriel F Berriz, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
American Journal of Human Genetics|June 6, 2023
Actionability of unanticipated monogenic disease risks in newborn genomic screening: Findings from the BabySeq ProjectRobert C Green, Nidhi Shah, Casie A Genetti, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 23, 2015
Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivityAhmed A Alfares, Melissa A Kelly, Gregory McDermott, et al.
Medrxiv : the Preprint Server for Health Sciences|November 14, 2023
Decoding Genetics, Ancestry, and Geospatial Context for Precision HealthSatoshi Koyama, Ying Wang, Kaavya Paruchuri, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 4, 2015
CORRIGENDUM: Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivityAhmed A Alfares, Melissa A Kelly, Gregory McDermott, et al.
American Journal of Human Genetics|November 9, 2021
Returning actionable genomic results in a research biobank: Analytic validity, clinical implementation, and resource utilizationCarrie L Blout Zawatsky, Nidhi Shah, Kalotina Machini, et al.
Cold Spring Harbor Molecular Case Studies|May 6, 2018
Reconciling newborn screening and a novel splice variant in <i>BTD</i> associated with partial biotinidase deficiency: a BabySeq Project case reportJaclyn B Murry, Kalotina Machini, Ozge Ceyhan-Birsoy, et al.
Journal of the American College of Cardiology|April 29, 2026
Development and Validation of a Clinical Polygenic Risk Report in U.S.-Based Health Systems for 8 Cardiovascular ConditionsAnika Misra, Amanda Jowell, Sara Haidermota, et al.
Genome Medicine|October 7, 2022
Patient and provider perspectives on polygenic risk scores: implications for clinical reporting and utilizationAnna C F Lewis, Emma F Perez, Anya E R Prince, et al.
Human Mutation|June 10, 2020
An assessment of the role of vinculin loss of function variants in inherited cardiomyopathyMegan H Hawley, Naif Almontashiri, Leslie G Biesecker, et al.
Nature Medicine|April 19, 2022
Development of a clinical polygenic risk score assay and reporting workflowLimin Hao, Peter Kraft, Gabriel F Berriz, et al.
Pageof 7